Forbes November 8, 2023
Weight loss prescriptions Wegovy, Rybelsus and Saxenda – along with Ozempic – are driving health costs for employers up by more than $300 per insured worker this year, new data from benefits consultancy Aon says.
These GLP-1 drug costs are expected to boost healthcare spending through 2025, increasing from $324 per insured member this year up to $500 per insured health plan member in two years, new data from the benefits consultancy Aon says. By comparison, annual spending on such prescriptions in 2021 was $96 per member, Aon data shows.
Aon’s analysis comes from its Aon Rx claims data from nearly 500 employers and their 4.4 million health plan members. Aon said weight loss prescriptions Wegovy, Rybelsus and Saxenda have...